InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by Cooper Warren d, Director. Director active across 1 company, notably Zynerba Pharmaceuticals, Inc.. In total, 4 disclosures have been recorded. History available since 3 August 2021. The latest transaction was filed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Warren D. Cooper is a Board Member at Zynerba Pharmaceuticals, Inc. He is involved in governance and strategic decision-making. With expertise in the pharmaceutical sector, Warren contributes to innovation and growth within the company.